Found: 131
Select item for more details and to access through your institution.
Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.
- Published in:
- Nephrology Dialysis Transplantation, 2004, v. 19, n. 9, p. 2275, doi. 10.1093/ndt/gfh362
- By:
- Publication type:
- Article
Anti-tumor effect and increased survival after treatment with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate in a rat liver micrometastases model.
- Published in:
- International Journal of Cancer, 2003, v. 104, n. 3, p. 376, doi. 10.1002/ijc.10952
- By:
- Publication type:
- Article
[
- Published in:
- International Journal of Cancer, 2001, v. 92, n. 5, p. 628, doi. 10.1002/1097-0215(20010601)92:5<628::AID-IJC1244>3.0.CO;2-L
- By:
- Publication type:
- Article
Pre-clinical evaluation of [.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 5, p. 657, doi. 10.1002/(SICI)1097-0215(19991126)83:5<657::AID-IJC15>3.0.CO;2-Y
- By:
- Publication type:
- Article
Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 5, p. 767, doi. 10.1002/(SICI)1097-0215(19990531)81:5<767::AID-IJC17>3.0.CO;2-T
- By:
- Publication type:
- Article
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 4, p. 658, doi. 10.1002/(SICI)1097-0215(19990517)81:4<658::AID-IJC24>3.0.CO;2-P
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1014, n. 1, p. 234, doi. 10.1196/annals.1294.026
- By:
- Publication type:
- Article
[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.
- Published in:
- Molecules, 2020, v. 25, n. 15, p. 3418, doi. 10.3390/molecules25153418
- By:
- Publication type:
- Article
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair.
- Published in:
- Molecules, 2019, v. 24, n. 6, p. 1015, doi. 10.3390/molecules24061015
- By:
- Publication type:
- Article
Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr³]Octreotate.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 9, p. 1361, doi. 10.2967/jnumed.111.087932
- By:
- Publication type:
- Article
Dynamic and Static Small-Animal SPECT in Rats for Monitoring Renal Function After <sup>177</sup>Lu-Labeled Tyr³-Octreotate Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 12, p. 1962, doi. 10.2967/jnumed.110.080143
- By:
- Publication type:
- Article
Nephrotoxicity in Mice After Repeated Imaging Using <sup>111</sup>In-Labeled Peptides.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 6, p. 973, doi. 10.2967/jnumed.109.074310
- By:
- Publication type:
- Article
Salvage Therapy with <sup>177</sup>Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 383, doi. 10.2967/jnumed.109.068957
- By:
- Publication type:
- Article
Pemetrexed Improves Tumor Selectivity of <sup>111</sup>In-DTPA-Folate in Mice with Folate Receptor-Positive Ovarian Cancer.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 4, p. 623, doi. 10.2967/jnumed.107.047704
- By:
- Publication type:
- Article
SPECT Study of Folate Receptor-Positive Malignant and Normal Tissues in Mice Using a Novel <sup>99m</sup>Tc-Radiofolate.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 2, p. 310, doi. 10.2967/jnumed.107.045856
- By:
- Publication type:
- Article
Androgen-Dependent Expression of the Gastrin-Releasing Peptide Receptor in Human Prostate Tumor Xenografts.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 1, p. 88
- By:
- Publication type:
- Article
Inhibition of Kidney Uptake of Radiolabeled Somatostatin Analogs: Amino Acids or Gelofusine?
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 10, p. 1730
- By:
- Publication type:
- Article
Effects of Therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>, Tyr³]Octreotate in Patients with Paraganglioma, Meningioma, Small Cell Lung Carcinoma, and Melanoma.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 10, p. 1599
- By:
- Publication type:
- Article
Impact of Diabetes Mellitus on Prediction of Clinical Outcome After Coronary Revascularization by <sup>18</sup>F-FDG SPECT in Patients with Ischemic Left Ventricular Dysfunction.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 1, p. 68
- By:
- Publication type:
- Article
Anticancer Activity of Targeted Proapoptotic Peptides.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 1, p. 122
- By:
- Publication type:
- Article
Oral Versus Intravenous Administration of Lysine: Equal Effectiveness in Reduction of Renal Uptake of [<sup>111</sup>In-DTPA]Octreotide.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 12, p. 2057
- By:
- Publication type:
- Article
Induction of Apoptosis with Hybrids of Arg-Gly-Asp Molecules and Peptides and Antimitotic Effects of Hybrids of Cytostatic Drugs and Peptides.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 191S
- By:
- Publication type:
- Article
Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 76S
- By:
- Publication type:
- Article
Practical Dosimetry of Peptide Receptor Radionuclide Therapy with <sup>90</sup>Y-Labeled Somatostatin Analogs.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 92S
- By:
- Publication type:
- Article
Patient-Specific Dosimetry in Predicting Renal Toxicity with <sup>90</sup>Y-DOTATOC: Relevance of Kidney Volume and Dose Rate in Finding a Dose--Effect Relationship.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 99S
- By:
- Publication type:
- Article
Long-Term Follow-Up of Renal Function After Peptide Receptor Radiation Therapy with <sup>90</sup>Y-DOTA<sup>0</sup>,Tyr³-Octreotide and <sup>177</sup>Lu-DOTA<sup>0</sup>, Tyr³-Octreotate.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 83S
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy for Non--Radioiodine-Avid Differentiated Thyroid Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 107S
- By:
- Publication type:
- Article
Candidates for Peptide Receptor Radiotherapy Today and in the Future.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 67S
- By:
- Publication type:
- Article
Overview of Results of Peptide Receptor Radionuclide Therapy with 3 Radiolabeled Somatostatin Analogs.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 62S
- By:
- Publication type:
- Article
Combination Radionuclide Therapy Using <sup>177</sup>Lu- and <sup>90</sup>Y-Labeled Somatostatin Analogs.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 13S
- By:
- Publication type:
- Article
A Pragmatic Perspective on Molecular Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 2, p. 1S
- By:
- Publication type:
- Article
Increased Cell Death After Therapy with an Arg-Gly-Asp-Linked Somatostatin Analog.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 10, p. 1716
- By:
- Publication type:
- Article
A Stylized Computational Model of the Rat for Organ Dosimetry in Support of Preclinical Evaluations of Peptide Receptor Radionuclide Therapy with 90Y, <sup>111</sup>In, or <sup>177</sup>Lu.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 7, p. 1260
- By:
- Publication type:
- Article
Inhomogeneous Localization of Radioactivity in the Human Kidney After Injection of [<sup>111</sup>In-DTPA]Octreotide.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 7, p. 1168
- By:
- Publication type:
- Article
Uptake of [<sup>111 </sup>In-DTPA<sup>0</sup>]Octreotide in the Rat Kidney Is Inhibited by Colchicine and Not by Fructose.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 4, p. 709
- By:
- Publication type:
- Article
Crucial Role for Somatostatin Receptor Subtype 2 in Determining the Uptake of [<sup>111</sup>In-DTPA-D-Phe¹]Octreotide in Somatostatin Receptor-Positive Organs.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 8, p. 1315
- By:
- Publication type:
- Article
Effect of Diabetes Mellitus on Myocardial <sup>18</sup>F-FDG SPECT Using Acipimox for the Assessment of Myocardial Viability.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 6, p. 877
- By:
- Publication type:
- Article
Feasibility and Image Quality of Dual-Isotope SPECT Using <sup>18</sup>F-FDG and <sup>99m</sup>Tc-Tetrofosmin After Acipimox Administration.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 2, p. 140
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy In Vitro Using [<sup>111</sup>In-DTPA<sup>0</sup>]Octreotide.
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 1, p. 98
- By:
- Publication type:
- Article
The Inhibitory Effect of <sup>111</sup>In-DTPA<sup>0</sup>-Octreotide on Intrahepatic Tumor Growth After Partial Hepatectomy.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 12, p. 1681
- By:
- Publication type:
- Article
Preclinical Comparison of <sup>111</sup>In-Labeled DTPA- or DOTA-Bombesin Analogs for Receptor-Targeted Scintigraphy and Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 12, p. 1650
- By:
- Publication type:
- Article
Tumor Response After [<sup>90</sup>Y-DOTA<sup>0</sup>,Tyr³]- Octreotide Radionuclide Therapy in a Transplantable Rat Tumor Model Is Dependent on Tumor Size.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 12, p. 1841
- By:
- Publication type:
- Article
Procedure Guideline for Somatostatin Receptor Scintigraphy with <sup>111</sup>In-Pentetreotide.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 7, p. 1134
- By:
- Publication type:
- Article
Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin's Lymphomas.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 2, p. 222
- By:
- Publication type:
- Article
Peptide Receptor Imaging and Therapy.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 10, p. 1704
- By:
- Publication type:
- Article
Preclinical and Initial Clinical Evaluation of <sup>111</sup>In-Labeled Nonsulfated CCK<sub>8</sub> Analog: A Peptide for CCK-B Receptor-Targeted Scintigraphy and Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 12, p. 2081
- By:
- Publication type:
- Article
Comparison of <sup>111</sup>In-DOTA-Tyr³-Octreotide and <sup>111</sup>In-DTPA-Octreotide in the Same Patients: Biodistribution, Kinetics, Organ and Tumor Uptake.
- Published in:
- Journal of Nuclear Medicine, 1999, v. 40, n. 5, p. 762
- By:
- Publication type:
- Article
Safety of Dobutamine-Atropine Stress Myocardial Perfusion Scintigraphy.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 10, p. 1662
- By:
- Publication type:
- Article
D-Lysine Reduction of Indium-111 Octreotide and Yttrium-90 Octreotide Renal Uptake.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 12, p. 1929
- By:
- Publication type:
- Article
Inhibition of Renal Uptake of Indium-111-DTPA-Octreotide In Vivo.
- Published in:
- Journal of Nuclear Medicine, 1996, v. 37, n. 8, p. 1388
- By:
- Publication type:
- Article